1. Meta-analysis of SGLT2i

The Lancet published “SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials”. 

The paper can be found free on www as a pdf at 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32590-X/fulltext

  1. The results of DECLARE-TIMI 58 were presented on Saturday November 10thby Dr Stephen Wiviott at the American Heart Association (AHA) Scientific Sessions in Chicago. 

The slides that were presented during the Late Breaking Clinical Trials session can be found here

http://www.timi.org/index.php?page=declare-slide-sets

  1. The original New England Journal of Medicine published “Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes”. 

The paper can be found at www free for you as a pdf

https://www.nejm.org/doi/full/10.1056/NEJMoa1812389

Nyhetsinfo

Www red DiabetologNytt

FacebookTwitterLinkedinGoogle Bookmarks